PMID: 13488272Oct 12, 1957Paper

Clinical toxicity of sulfonamides

Annals of the New York Academy of Sciences
D LEHR

Abstract

No abstract listed.

References

Mar 1, 1954·American Journal of Proctology
Dec 1, 1949·The Journal of Urology·H T THOMPSON
Jan 14, 1950·Journal of the American Medical Association·G CARROLLH FLYNN
Jan 1, 1940·The Journal of Clinical Investigation·I VignessW W Spink
Sep 1, 1941·The Journal of Clinical Investigation·C L Fox, R Ottenberg
Mar 1, 1949·The Journal of Urology·J A LAZARUS, L H SCHWARZ
May 1, 1948·Proceedings of the Society for Experimental Biology and Medicine·S J SARNOFF
Mar 6, 1948·Journal of the American Medical Association·F C LOWELL
Apr 1, 1948·The Journal of Urology·R S RODGERS, F H COLBY
Apr 1, 1947·Proceedings of the Society for Experimental Biology and Medicine·D LEHR
Jun 1, 1947·The American Journal of Medicine·W B SHERMAN, R A COOKE
Dec 4, 1947·The New England Journal of Medicine·P H LONG
Mar 1, 1947·The Journal of Allergy·M B SULZBERGER, A KANOF
Jan 1, 1943·Canadian Medical Association Journal·M A Simon, M Kaufmann
May 24, 1941·British Medical Journal·D F Johnstone, P Forgacs
Jan 3, 1942·British Medical Journal·A J Steigman
Mar 14, 1942·British Medical Journal·E L Cohen
Jul 17, 1943·British Medical Journal·R G Park
Jun 10, 1944·British Medical Journal·R G Park

❮ Previous
Next ❯

Citations

May 1, 1972·The Journal of Clinical Pharmacology and New Drugs·D Lehr
Nov 10, 1960·The New England Journal of Medicine·L WEINSTEINC M SAMET
Jan 3, 1963·The New England Journal of Medicine·P V BARRETT, S O THIER
Dec 23, 1965·The New England Journal of Medicine·J M LeedomP F Wehrle
Sep 12, 1968·The New England Journal of Medicine·L Weinstein, A C Dalton
Dec 1, 1994·Journal of Endourology·D M AlbalaH A Galal
Mar 1, 2012·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Robert S Pinals, Eve Golden
Sep 1, 1976·International Journal of Dermatology·L E Millikan, R Goldner
Aug 1, 1973·Australian and New Zealand Journal of Medicine·W R AdamJ K Dawborn
Sep 19, 1959·British Medical Journal
Aug 13, 2011·Nephron. Clinical Practice·Pierre DelanayeChristine A White
Mar 30, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Paul M KoblicTodd C Lee
Feb 12, 2004·Drugs·Michel Daudon, Paul Jungers
Apr 9, 2015·Clinical Kidney Journal·Hassane IzzedineFabrice Bonnet
Jul 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L G CarboneG B Appel
Nov 7, 2016·International Journal of Surgery·Colin J McCarthyAvinash Kambadakone
Mar 1, 1981·International Journal of Dermatology·J E Bernstein, A L Lorincz
Sep 1, 1989·DICP : the Annals of Pharmacotherapy·C M Paap, M C Nahata
Apr 1, 1983·Drug Intelligence & Clinical Pharmacy·T B VreeR van Dalen
Feb 1, 1980·Klinische Wochenschrift·E Heidbreder, A Heidland
Sep 1, 1959·Annals of the New York Academy of Sciences·W P BOGER, J J GAVIN
Oct 1, 1967·The Journal of Urology·L I Schainuck, J E Hano
Aug 1, 1970·Australasian Annals of Medicine·W R Adam, J K Dawborn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of the New York Academy of Sciences
W F JONES, M FINLAND
Scandinavian Journal of Urology and Nephrology
O S Alfthan, K Liewendahl
© 2021 Meta ULC. All rights reserved